e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Tuberculosis and immunologic assays
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of Quantiferon TB Gold intensity response in active over latent tuberculosis
F. Khan, O. Cotter, J. Clair, D. Curran, T. O‘Connor (Cork, Ireland)
Source:
Annual Congress 2012 - Tuberculosis and immunologic assays
Session:
Tuberculosis and immunologic assays
Session type:
Poster Discussion
Number:
419
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Khan, O. Cotter, J. Clair, D. Curran, T. O‘Connor (Cork, Ireland). Impact of Quantiferon TB Gold intensity response in active over latent tuberculosis. Eur Respir J 2012; 40: Suppl. 56, 419
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
ERS short guidelines on COVID-19 management
Influenza vaccination: protecting the most vulnerable
Understanding new vaccines for SARS-CoV-2 and their regulation
Related content which might interest you:
Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment
Source: International Congress 2017 – Migrants and screening
Year: 2017
Quantiferon–TB Gold test in cases of active pulmonary tuberculosis initially and during treatment
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Role of the QuantiFERON®-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection
Source: Eur Respir J 2012; 40: 1443-1449
Year: 2012
Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
QuantiFERON-TB Gold for detection of latent and active tuberculosis infection in immunocompromised versus immune-competent
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013
QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2012; 39: 163-171
Year: 2012
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2011; 39: 163-171
Year: 2012
The prevalence of latent tuberculosis infection in a children social center: Comparison of QuantiFERON-TB Gold with tuberculin skin testing
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010
Diagnosis of latent tuberculosis infection (LTBI) by quantiFERON®-TB gold test – QFT in homeless people in Poland
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Absence of response to Quantiferon-TB Gold is associated to severe tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Importance of QuantiFERON-TB Gold and tuberculin skin test in the differential diagnosis of active and inactive pulmonary tuberculosis
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Comparison between tuberculin skin testing and QuantiFERON Gold-In Tube for detection of latent tuberculosis in rheumatoid arthritis patients in a TB endemic population
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Comparison of tuberculin skin test (TST) and QuantiFERON-TB-Gold in Tube (QFT) in the diagnosis of latent tuberculosis infection (LTBI) in a prospective community study of contacts of tuberculosis (TB)
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
QuantiFERON-TB GIT (QFT-GIT)
vs
TST in diagnosis of latent tuberculosis (TB) infection (LTBI) in household TB contacts in poland
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept